Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clopidogrel and warfarin pharmacogenetic tests: what is the evidence for use in clinical practice?

Current opinion in cardiology - 1 May 2013

Shahin Mohamed H A, Johnson Julie A

Abstract excerpt

PURPOSE OF REVIEW: To review the most promising genetic markers associated with the variability in the safety or efficacy of warfarin and clopidogrel and highlight the verification and validation initiatives for translating clopidogrel and warfarin pharmacogenetic tests to clinical practice. RECENT FINDINGS: Rapid advances in pharmacogenetics, continuous decrease in genotyping cost, development of point-of-care...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticoagulants
Share to Aryl Hydrocarbon Hydroxylases
Share to Clopidogrel

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP2C19

Share to Cytochrome P-450 CYP2C9

Share to Platelet Aggregation Inhibitors

Share to Ticlopidine

Share to Warfarin

Source

Open in PubMed Open full text

Identifiers

PMID: 23478884
DOI: 10.1097/HCO.0b013e32835f0bbc
PMCID: PMC3731766

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clopidogrel and warfarin pharmacogenetic tests: what is the evidence for use in clinical practice?PMID 23478884Read ↗

Pharmacogenetics of Antiplatelet Therapy.Semantic proximity Read ↗

Clopidogrel and genetic testing: is it necessary for everyone?Semantic proximity Read ↗

Clopidogrel PharmacogeneticsSemantic proximity Read ↗

Pharmacogenetics in Oral Antithrombotic Therapy.Semantic proximity Read ↗

Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update.Semantic proximity Read ↗

Pharmacogenetics and cardiovascular disease--implications for personalized medicine.Semantic proximity Read ↗

Pharmacogenetics of antiplatelet therapy.Semantic proximity Read ↗

Genotyping genetic variants of CYP2C19 for precision antiplatelet dosing: state of the art and future perspectives.Semantic proximity Read ↗

Pharmacogenetics of Clopidogrel: An Unresolved Issue.Semantic proximity Read ↗

The Role of Pharmacogenetics in Antithrombotic Therapy Management: New Achievements and Barriers Yet to OvercomeSemantic proximity Read ↗

Pharmacogenetics and clopidogrel response in patients undergoing percutaneous coronary interventions.Semantic proximity Read ↗

The pharmacogenetics of antiplatelet agents: towards personalized therapy?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.